Literature DB >> 28225594

Mass Spectral Feature List Optimizer (MS-FLO): A Tool To Minimize False Positive Peak Reports in Untargeted Liquid Chromatography-Mass Spectroscopy (LC-MS) Data Processing.

Brian C DeFelice1, Sajjan Singh Mehta1, Stephanie Samra1, Tomáš Čajka1, Benjamin Wancewicz1, Johannes F Fahrmann1,2, Oliver Fiehn1,3.   

Abstract

Untargeted metabolomics by liquid chromatography-mass spectrometry generates data-rich chromatograms in the form of m/z-retention time features. Managing such datasets is a bottleneck. Many popular data processing tools, including XCMS-online and MZmine2, yield numerous false-positive peak detections. Flagging and removing such false peaks manually is a time-consuming task and prone to human error. We present a web application, Mass Spectral Feature List Optimizer (MS-FLO), to improve the quality of feature lists after initial processing to expedite the process of data curation. The tool utilizes retention time alignments, accurate mass tolerances, Pearson's correlation analysis, and peak height similarity to identify ion adducts, duplicate peak reports, and isotopic features of the main monoisotopic metabolites. Removing such erroneous peaks reduces the overall number of metabolites in data reports and improves the quality of subsequent statistical investigations. To demonstrate the effectiveness of MS-FLO, we processed 28 biological studies and uploaded raw and results data to the Metabolomics Workbench website ( www.metabolomicsworkbench.org ), encompassing 1481 chromatograms produced by two different data processing programs used in-house (MZmine2 and later MS-DIAL). Post-processing of datasets with MS-FLO yielded a 7.8% automated reduction of total peak features and flagged an additional 7.9% of features, per dataset, for review by the user. When manually curated, 87% of these additional flagged features were verified false positives. MS-FLO is an open source web application that is freely available for use at http://msflo.fiehnlab.ucdavis.edu .

Entities:  

Mesh:

Year:  2017        PMID: 28225594      PMCID: PMC7334838          DOI: 10.1021/acs.analchem.6b04372

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  10 in total

Review 1.  Toward Merging Untargeted and Targeted Methods in Mass Spectrometry-Based Metabolomics and Lipidomics.

Authors:  Tomas Cajka; Oliver Fiehn
Journal:  Anal Chem       Date:  2015-12-16       Impact factor: 6.986

2.  XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification.

Authors:  Colin A Smith; Elizabeth J Want; Grace O'Maille; Ruben Abagyan; Gary Siuzdak
Journal:  Anal Chem       Date:  2006-02-01       Impact factor: 6.986

3.  Time-saving design of experiment protocol for optimization of LC-MS data processing in metabolomic approaches.

Authors:  Hong Zheng; Morten Rahr Clausen; Trine Kastrup Dalsgaard; Grith Mortensen; Hanne Christine Bertram
Journal:  Anal Chem       Date:  2013-07-24       Impact factor: 6.986

4.  Strategy for optimizing LC-MS data processing in metabolomics: a design of experiments approach.

Authors:  Mattias Eliasson; Stefan Rännar; Rasmus Madsen; Magdalena A Donten; Emma Marsden-Edwards; Thomas Moritz; John P Shockcor; Erik Johansson; Johan Trygg
Journal:  Anal Chem       Date:  2012-07-26       Impact factor: 6.986

5.  Ion fusion of high-resolution LC-MS-based metabolomics data to discover more reliable biomarkers.

Authors:  Zhongda Zeng; Xinyu Liu; Weidong Dai; Peiyuan Yin; Lina Zhou; Qiang Huang; Xiaohui Lin; Guowang Xu
Journal:  Anal Chem       Date:  2014-03-26       Impact factor: 6.986

6.  CAMERA: an integrated strategy for compound spectra extraction and annotation of liquid chromatography/mass spectrometry data sets.

Authors:  Carsten Kuhl; Ralf Tautenhahn; Christoph Böttcher; Tony R Larson; Steffen Neumann
Journal:  Anal Chem       Date:  2011-12-12       Impact factor: 6.986

7.  MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data.

Authors:  Tomás Pluskal; Sandra Castillo; Alejandro Villar-Briones; Matej Oresic
Journal:  BMC Bioinformatics       Date:  2010-07-23       Impact factor: 3.169

8.  ALLocator: an interactive web platform for the analysis of metabolomic LC-ESI-MS datasets, enabling semi-automated, user-revised compound annotation and mass isotopomer ratio analysis.

Authors:  Nikolas Kessler; Frederik Walter; Marcus Persicke; Stefan P Albaum; Jörn Kalinowski; Alexander Goesmann; Karsten Niehaus; Tim W Nattkemper
Journal:  PLoS One       Date:  2014-11-26       Impact factor: 3.240

9.  Metabolomics Workbench: An international repository for metabolomics data and metadata, metabolite standards, protocols, tutorials and training, and analysis tools.

Authors:  Manish Sud; Eoin Fahy; Dawn Cotter; Kenan Azam; Ilango Vadivelu; Charles Burant; Arthur Edison; Oliver Fiehn; Richard Higashi; K Sreekumaran Nair; Susan Sumner; Shankar Subramaniam
Journal:  Nucleic Acids Res       Date:  2015-10-13       Impact factor: 16.971

10.  MS-DIAL: data-independent MS/MS deconvolution for comprehensive metabolome analysis.

Authors:  Hiroshi Tsugawa; Tomas Cajka; Tobias Kind; Yan Ma; Brendan Higgins; Kazutaka Ikeda; Mitsuhiro Kanazawa; Jean VanderGheynst; Oliver Fiehn; Masanori Arita
Journal:  Nat Methods       Date:  2015-05-04       Impact factor: 28.547

  10 in total
  39 in total

1.  Mass Spectrometry Fingerprints of Small-Molecule Metabolites in Biofluids: Building a Spectral Library of Recurrent Spectra for Urine Analysis.

Authors:  Yamil Simón-Manso; Ramesh Marupaka; Xinjian Yan; Yuxue Liang; Kelly H Telu; Yuri Mirokhin; Stephen E Stein
Journal:  Anal Chem       Date:  2019-08-30       Impact factor: 6.986

2.  Perspectives on Data Analysis in Metabolomics: Points of Agreement and Disagreement from the 2018 ASMS Fall Workshop.

Authors:  Erin S Baker; Gary J Patti
Journal:  J Am Soc Mass Spectrom       Date:  2019-08-22       Impact factor: 3.109

3.  Peak Annotation and Verification Engine for Untargeted LC-MS Metabolomics.

Authors:  Lin Wang; Xi Xing; Li Chen; Lifeng Yang; Xiaoyang Su; Herschel Rabitz; Wenyun Lu; Joshua D Rabinowitz
Journal:  Anal Chem       Date:  2019-01-10       Impact factor: 6.986

Review 4.  Chemical Discovery in the Era of Metabolomics.

Authors:  Miriam Sindelar; Gary J Patti
Journal:  J Am Chem Soc       Date:  2020-05-11       Impact factor: 15.419

5.  Deep annotation of untargeted LC-MS metabolomics data with Binner.

Authors:  Maureen Kachman; Hani Habra; William Duren; Janis Wigginton; Peter Sajjakulnukit; George Michailidis; Charles Burant; Alla Karnovsky
Journal:  Bioinformatics       Date:  2020-03-01       Impact factor: 6.937

6.  Metabolomics-related nutrient patterns at seroconversion and risk of progression to type 1 diabetes.

Authors:  Randi K Johnson; Lauren A Vanderlinden; Brian C DeFelice; Ulla Uusitalo; Jennifer Seifert; Sili Fan; Tessa Crume; Oliver Fiehn; Marian Rewers; Katerina Kechris; Jill M Norris
Journal:  Pediatr Diabetes       Date:  2020-08-09       Impact factor: 4.866

Review 7.  Cardiovascular Metabolomics.

Authors:  Robert W McGarrah; Scott B Crown; Guo-Fang Zhang; Svati H Shah; Christopher B Newgard
Journal:  Circ Res       Date:  2018-04-27       Impact factor: 17.367

8.  In-Source CID Ramping and Covariant Ion Analysis of Hydrophilic Interaction Chromatography Metabolomics.

Authors:  Xiaoyang Su; Eric Chiles; Sara Maimouni; Fredric E Wondisford; Wei-Xing Zong; Chi Song
Journal:  Anal Chem       Date:  2020-03-13       Impact factor: 6.986

Review 9.  Identification of small molecules using accurate mass MS/MS search.

Authors:  Tobias Kind; Hiroshi Tsugawa; Tomas Cajka; Yan Ma; Zijuan Lai; Sajjan S Mehta; Gert Wohlgemuth; Dinesh Kumar Barupal; Megan R Showalter; Masanori Arita; Oliver Fiehn
Journal:  Mass Spectrom Rev       Date:  2017-04-24       Impact factor: 10.946

10.  Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice.

Authors:  Tim Hendrikx; Yi Duan; Yanhan Wang; Jee-Hwan Oh; Laura M Alexander; Wendy Huang; Peter Stärkel; Samuel B Ho; Bei Gao; Oliver Fiehn; Patrick Emond; Harry Sokol; Jan-Peter van Pijkeren; Bernd Schnabl
Journal:  Gut       Date:  2018-11-17       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.